Kijk op onze speciale pagina met aanbestedingen van medisch materiaal in verband met de coronacrisis.
Verenigd Koninkrijk-Cardiff: Laboratoriumreagentia
Aankondiging in geval van vrijwillige transparantie vooraf
Afdeling I: Aanbestedende dienst/instantie
Adres van het kopersprofiel: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
Afdeling II: Voorwerp
Covid-19 Antibody Testing on the Liasion XL Platform in Microbiology Lab (UHW)
NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to the Covid-19 global pandemic they are awarding a contract for the provision of testing kits, equipment, reagents and any other associated consumables required to operate the testing platforms.
The UK government has mandated UK Health Boards and Trusts to carry out antibody and antigen testing for the wider population as well as those working in healthcare and care settings.
Therefore in order to enable the provision of these testing kits, equipment, reagent and other associated consumables required to operate the testing platforms, Public Health Wales would like to inform the market that under Regulation 32 (2) (C) of the Public Contracts Regulations 2015 (PCR’s) as detailed in UK Government guidance PPN 01/20 they are awarding a contract to Diasorin.
The Trust has met all the tests for awarding a contract under this regulation due to the immediate risk that Covid-19 poses to the population of Wales.
Afdeling IV: Procedure
Coronavirus disease (Covid-19) is an infection disease caused by a newly discovered Coronavirus.
The UK Government published the requirement for testing to be available for healthcare professionals, key workers and the wider population of Wales, to monitor and work to prevent the rate of the spread of infection.
Following engagement with the market and the Public Health Wales Microbiology department, the testing kits, equipment, reagent and other associated consumables required to operate the testing platforms were deemed clinically acceptable and the products have been available for immediate purchase within the market.
The award of these products enables the Trust to increase their testing capacity, in line with the expectations and demands of the Welsh Government strategy in tackling the Coronavirus (Covid-19) pandemic.
In these exceptional circumstances, there is no time to run an accelerated procedure in line with PCR’s as there is an urgent requirement for suitable testing kits, equipment, reagents and other associated consumables required to support the use of the testing platforms.
Based on the above, the authority is applying a 10 day standstill period to allow suppliers in the marketplace an opportunity to appeal if they believe they have the capacity to meet the Trusts unique and urgent requirements.
Afdeling V: Gunning van een opdracht/concessieovereenkomst
Afdeling VI: Aanvullende inlichtingen
Note: to register your interest in this notice and obtain any additional information please visit the Sell2Wales website at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=101989
NHS Wales Shared Services Partnership on behalf of Public Health Wales Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Should additional information be required it should be requested of the addressee in section I.1). Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments).